These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31400756)

  • 41. Genetic diversity of influenza A viruses circulating in Bulgaria during the 2018-2019 winter season.
    Korsun N; Daniels R; Angelova S; Ermetal B; Grigorova I; Voleva S; Trifonova I; Kurchatova A; McCauley J
    J Med Microbiol; 2020 Jul; 69(7):986-998. PubMed ID: 32459617
    [No Abstract]   [Full Text] [Related]  

  • 42. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution.
    Koel BF; Burke DF; Bestebroer TM; van der Vliet S; Zondag GC; Vervaet G; Skepner E; Lewis NS; Spronken MI; Russell CA; Eropkin MY; Hurt AC; Barr IG; de Jong JC; Rimmelzwaan GF; Osterhaus AD; Fouchier RA; Smith DJ
    Science; 2013 Nov; 342(6161):976-9. PubMed ID: 24264991
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination with 2014-15 Seasonal Inactivated Influenza Vaccine Elicits Cross-Reactive Anti-HA Antibodies with Strong ADCC Against Antigenically Drifted Circulating H3N2 Virus in Humans.
    Zhong W; Gross FL; Holiday C; Jefferson SN; Bai Y; Liu F; Katz JM; Levine MZ
    Viral Immunol; 2016 May; 29(4):259-62. PubMed ID: 26950058
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modular epitope binding predicts influenza quasispecies dominance and vaccine effectiveness: Application to 2018/19 season.
    Bonomo ME; Kim RY; Deem MW
    Vaccine; 2019 May; 37(24):3154-3158. PubMed ID: 31060950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infection of Ferrets with Influenza Virus Elicits a Light Chain-Biased Antibody Response against Hemagglutinin.
    Kirchenbaum GA; Allen JD; Layman TS; Sautto GA; Ross TM
    J Immunol; 2017 Dec; 199(11):3798-3807. PubMed ID: 29079697
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Passage Adaptation Correlates With the Reduced Efficacy of the Influenza Vaccine.
    Chen H; Alvarez JJS; Ng SH; Nielsen R; Zhai W
    Clin Infect Dis; 2019 Sep; 69(7):1198-1204. PubMed ID: 30561532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine.
    Wu NC; Zost SJ; Thompson AJ; Oyen D; Nycholat CM; McBride R; Paulson JC; Hensley SE; Wilson IA
    PLoS Pathog; 2017 Oct; 13(10):e1006682. PubMed ID: 29059230
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sequence analysis of the HA1 regions of hemagglutinin gene from influenza viruses (H3N2) isolated from children in Beijing in 2004 indicated antigenic variation].
    Zhu RN; Xu H; Qian Y; Wang F; Deng J; Zhao LQ; Liao B; Huang RY
    Zhonghua Er Ke Za Zhi; 2005 Sep; 43(9):653-6. PubMed ID: 16191295
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Virological characterization of influenza A(H3N2) virus in Mainland China during 2011-2012].
    Huang WJ; Cheng YH; Li XY; Zhao X; Guo JF; Wang Z; Tan MJ; Li M; Sui HT; Wei HJ; Chen YY; Xiao N; Lan Y; Wang DY; Shu YL
    Bing Du Xue Bao; 2013 May; 29(3):258-64. PubMed ID: 23905468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012-2013.
    Cobey S; Gouma S; Parkhouse K; Chambers BS; Ertl HC; Schmader KE; Halpin RA; Lin X; Stockwell TB; Das SR; Landon E; Tesic V; Youngster I; Pinsky BA; Wentworth DE; Hensley SE; Grad YH
    Clin Infect Dis; 2018 Jul; 67(3):327-333. PubMed ID: 29471464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Predominance of influenza A(H3N2) virus genetic subclade 3C.2a1 during an early 2016/17 influenza season in Europe - Contribution of surveillance data from World Health Organization (WHO) European Region to the WHO vaccine composition consultation for northern hemisphere 2017/18.
    Melidou A; Broberg E;
    Vaccine; 2017 Sep; 35(37):4828-4835. PubMed ID: 28780977
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic and antigenic relatedness of H3 subtype influenza A viruses isolated from avian and mammalian species.
    Yassine HM; Lee CW; Suarez DL; Saif YM
    Vaccine; 2008 Feb; 26(7):966-77. PubMed ID: 18206275
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Addition of N-glycosylation sites on the globular head of the H5 hemagglutinin induces the escape of highly pathogenic avian influenza A H5N1 viruses from vaccine-induced immunity.
    Hervé PL; Lorin V; Jouvion G; Da Costa B; Escriou N
    Virology; 2015 Dec; 486():134-45. PubMed ID: 26433051
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011.
    Ann J; Papenburg J; Bouhy X; Rhéaume C; Hamelin MÈ; Boivin G
    J Clin Virol; 2012 Jan; 53(1):88-92. PubMed ID: 22036039
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure and receptor binding preferences of recombinant human A(H3N2) virus hemagglutinins.
    Yang H; Carney PJ; Chang JC; Guo Z; Villanueva JM; Stevens J
    Virology; 2015 Mar; 477():18-31. PubMed ID: 25617824
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influenza H3N2 Vaccines: Recent Challenges.
    Mostafa A; Pleschka S
    Trends Microbiol; 2018 Feb; 26(2):87-89. PubMed ID: 29268980
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting Egg Passage Adaptations to Design Better Vaccines for the H3N2 Influenza Virus.
    Liu Y; Chen H; Duan W; Zhang X; He X; Nielsen R; Ma L; Zhai W
    Viruses; 2022 Sep; 14(9):. PubMed ID: 36146872
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1.
    Nakowitsch S; Wolschek M; Morokutti A; Ruthsatz T; Krenn BM; Ferko B; Ferstl N; Triendl A; Muster T; Egorov A; Romanova J
    Vaccine; 2011 Apr; 29(19):3517-24. PubMed ID: 21406268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular and antigenic characterization of the H3 hemagglutinin of H3N2 influenza A virus strains collected in the Czech Republic during the 2014/2015 epidemic season.
    Nagy A; Jiřincová H; Kynčl J; Havlíčková M
    Epidemiol Mikrobiol Imunol; 2016; 65(2):92-101. PubMed ID: 27467326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.